IP Verse

Progenics Pharmaceuticals competitive analysis

Loading summary...

Latest patents of Progenics Pharmaceuticals opposed by its competitors

Explore Progenics Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3263571
Aug 23, 2023Crystal Form Of (R)-N-Methylnaltrexone Bromide And Uses Thereof1

Latest publications and patents of Progenics Pharmaceuticals New

Explore the latest publications and patents granted to Progenics Pharmaceuticals, showcasing their recent innovations and technological advancements.

Last updated on: Oct 21, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Progenics Pharmaceuticals

EP3263571
Aug 23, 2023Crystal Form Of (R)-N-Methylnaltrexone Bromide And Uses ThereofPatent Maintained As Amended

Latest PTAB cases involving Progenics Pharmaceuticals

Discover the latest PTAB cases involving Progenics Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 27, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Progenics Pharmaceuticals

IPR2025-00725Mar 14, 2025MIM SOFTWAREPROGENICS PHARMACEUTICALSInstitution Denied
IPR2025-00726Mar 14, 2025MIM SOFTWAREPROGENICS PHARMACEUTICALSInstitution Denied
IPR2025-00630Feb 21, 2025MIM SOFTWAREPROGENICS PHARMACEUTICALSInstitution Denied
PGR2019-00052Jul 29, 2019PROGENICS PHARMACEUTICALSMAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EVFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Progenics Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
PROGENICS PHARMACEUTICALS - 113
ISARPATENT12 - - -
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV - - - 1
MIM SOFTWARE - - 4 -